{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:59:30Z","timestamp":1783814370046,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K024418\/1"],"award-info":[{"award-number":["MR\/K024418\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030678","name":"Helmut Ecker Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030678","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xops.2025.100980","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:04:11Z","timestamp":1761131051000},"page":"100980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["CTx001 for Geographic Atrophy: A Gene Therapy Expressing Soluble, Truncated Complement Receptor 1 (Mini-CR1)"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0484-9952","authenticated-orcid":false,"given":"Sonika","family":"Rathi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Didangelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5929-4048","authenticated-orcid":false,"given":"Sofiya","family":"Pisarenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatia","family":"Zafeiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Emery-Billcliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakul","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Whalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Zamiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4904-498X","authenticated-orcid":false,"given":"Viranga","family":"Tilakaratna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4226-9166","authenticated-orcid":false,"given":"Ewa","family":"Szula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafiq","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"Munye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-9111","authenticated-orcid":false,"given":"Richard D.","family":"Unwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7937-7932","authenticated-orcid":false,"given":"Paul N.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8394-8355","authenticated-orcid":false,"given":"Simon J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.100980_bib1","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.ophtha.2017.05.035","article-title":"Prevalence of age-related macular degeneration in Europe: the past and the future","volume":"124","author":"Colijn","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100980_bib2","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.xops.2025.100980_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101243","article-title":"Investing in vision: innovation in retinal therapeutics and the influence on venture capital investment","volume":"99","author":"Hristodorov","year":"2024","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2025.100980_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103757","article-title":"Therapeutic targeting of the complement system in ocular disease","volume":"28","author":"Rathi","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.xops.2025.100980_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/imr.13145","article-title":"Age-related macular degeneration: a disease of extracellular complement amplification","volume":"313","author":"de Jong","year":"2023","journal-title":"Immunol Rev"},{"key":"10.1016\/j.xops.2025.100980_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.11.005","article-title":"Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy","volume":"45","author":"Whitmore","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2025.100980_bib7","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.ajpath.2014.07.017","article-title":"The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning","volume":"184","author":"Mullins","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.xops.2025.100980_bib8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.exer.2011.06.015","article-title":"Elevated membrane attack complex in human choroid with high risk complement factor H genotypes","volume":"93","author":"Mullins","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100980_bib9","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.ajpath.2019.04.005","article-title":"Choriocapillaris degeneration in geographic atrophy","volume":"189","author":"Sohn","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.xops.2025.100980_bib10","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ajhg.2021.05.015","article-title":"Beyond factor H: the impact of genetic variants with age-related macular degeneration on circulating factor H-like 1 and factor H-related protein concentrations","volume":"108","author":"Cipriani","year":"2021","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.xops.2025.100980_bib11","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41467-020-14499-3","article-title":"Increased circulating levels of factor H-related protein 4 are strongly associated with age-related macular degeneration","volume":"11","author":"Cipriani","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.xops.2025.100980_bib12","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ajhg.2021.06.002","article-title":"Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration","volume":"108","author":"Lor\u00e9s-Motta","year":"2021","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.xops.2025.100980_bib13","article-title":"Loss of CFHR5 function reduces the risk for age-related macular degeneration","volume":"2024","author":"Reeve","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.xops.2025.100980_bib14","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1038\/s41467-022-31085-x","article-title":"A proteogenomic signature of age-related macular degeneration in blood","volume":"13","author":"Emilsson","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.xops.2025.100980_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-93708-5","article-title":"FHL-1 interacts with human RPE cells through the \u03b15\u03b21 integrin and confers protection against oxidative stress","volume":"11","author":"Choudhury","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2025.100980_bib16","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M605083200","article-title":"His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form","volume":"281","author":"Clark","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.xops.2025.100980_bib17","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3389\/fimmu.2017.01778","article-title":"Bruch\u2019s membrane compartmentalizes complement regulation in the eye with implications for therapeutic design in age-related macular degeneration","volume":"8","author":"Clark","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.xops.2025.100980_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj2640581","article-title":"Functional properties of membrane cofactor protein of complement","volume":"264","author":"Seya","year":"1989","journal-title":"Biochem J"},{"key":"10.1016\/j.xops.2025.100980_bib19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.15252\/embj.201593673","article-title":"Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode","volume":"35","author":"Forneris","year":"2016","journal-title":"EMBO J"},{"key":"10.1016\/j.xops.2025.100980_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nsmb.3427","article-title":"Regulator-dependent mechanisms of C3b processing by factor i allow differentiation of immune responses","volume":"24","author":"Xue","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.xops.2025.100980_bib21","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.4049\/jimmunol.156.12.4821","article-title":"Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component","volume":"156","author":"Lambris","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.xops.2025.100980_bib22","article-title":"Enrichment of bruch\u2019s membrane from human donor eyes","volume":"105","author":"McHarg","year":"2015","journal-title":"J Vis Exp"},{"key":"10.1016\/j.xops.2025.100980_bib23","first-page":"1952","article-title":"Pharmacological characterization of the novel complement C3 inhibitor BI-C","volume":"65","author":"Kreideweiss","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100980_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002103","article-title":"Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey","volume":"3","author":"Vandenberghe","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.xops.2025.100980_bib25","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1073\/pnas.74.4.1683","article-title":"Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms","volume":"74","author":"Fearon","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.xops.2025.100980_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4049\/jimmunol.118.1.362","article-title":"Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS)","volume":"118","author":"Morrison","year":"1977","journal-title":"J Immunol"},{"key":"10.1016\/j.xops.2025.100980_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0022-1759(89)90248-2","article-title":"Preparation of monoclonal antibodies to C3b by immunization with C3b(i)-Sepharose","volume":"120","author":"Tosic","year":"1989","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.xops.2025.100980_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s42003-023-04431-y","article-title":"The neoepitope of the complement C5b-9 membrane attack complex is formed by proximity of adjacent ancillary regions of C9","volume":"6","author":"Bayly-Jones","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.xops.2025.100980_bib29","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65753-7","article-title":"Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model","volume":"153","author":"Tobe","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.xops.2025.100980_bib30","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100980_bib31","doi-asserted-by":"crossref","first-page":"20991","DOI":"10.1074\/jbc.M111.226266","article-title":"Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization","volume":"286","author":"Liu","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.xops.2025.100980_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4049\/jimmunol.174.1.491","article-title":"Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization","volume":"174","author":"Bora","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.xops.2025.100980_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019078","article-title":"A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration","volume":"6","author":"Cashman","year":"2011","journal-title":"PLOS One"},{"key":"10.1016\/j.xops.2025.100980_bib34","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2353\/ajpath.2010.091168","article-title":"Role of ocular complement factor h in a murine model of choroidal neovascularization","volume":"177","author":"Lyzogubov","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.xops.2025.100980_bib35","first-page":"293","article-title":"In vivo expression and efficacy following subretinal delivery of GT005, an investigational gene therapy for the treatment of geographic atrophy (GA)","volume":"63","author":"Stampoulis","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100980_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jim.2009.11.003","article-title":"Preparing serum for functional complement assays","volume":"352","author":"Lachmann","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.xops.2025.100980_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.imbio.2018.09.002","article-title":"Are rats more human than mice?","volume":"224","author":"Wildner","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.xops.2025.100980_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.xops.2025.100980_bib39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archopht.1964.00970020380016","article-title":"The ultrastructure of Bruch\u2019s membrane: I. human, monkey, rabbit, guinea pig, and rat eyes","volume":"72","author":"Nakaizumi","year":"1964","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2025.100980_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109134","article-title":"New approaches to the treatment of age-related macular degeneration (AMD)","volume":"221","author":"Csaky","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100980_bib41","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.3390\/jcm12082870","article-title":"Bruch\u2019s membrane: a key consideration with complement-based therapies for age-related macular degeneration","volume":"12","author":"Hammadi","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xops.2025.100980_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110343","article-title":"Breaking Bruch\u2019s: how changes in Bruch\u2019s membrane influence retinal homeostasis","volume":"255","author":"Clark","year":"2025","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100980_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.13166","article-title":"The factor H protein family: the switchers of the complement alternative pathway","volume":"313","author":"Lucientes-Continente","year":"2023","journal-title":"Immunol Rev"},{"key":"10.1016\/j.xops.2025.100980_bib44","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3389\/fimmu.2020.01297","article-title":"Interaction of the factor H family proteins FHR-1 and FHR-5 with DNA and dead cells: implications for the regulation of complement activation and opsonization","volume":"11","author":"K\u00e1rp\u00e1ti","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.xops.2025.100980_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-44605-0","article-title":"Levels of complement factor H-related 4 protein do not influence susceptibility to age-related macular degeneration or its course of progression","volume":"15","author":"Zouache","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.xops.2025.100980_bib46","series-title":"The Complement FactsBook","first-page":"361","article-title":"CD59","author":"Morgan","year":"2018"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525002787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525002787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:52:54Z","timestamp":1773834774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525002787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666914525002787"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.100980","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CTx001 for Geographic Atrophy: A Gene Therapy Expressing Soluble, Truncated Complement Receptor 1 (Mini-CR1)","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.100980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100980"}}